Institution
Government of India
Government•New Delhi, India•
About: Government of India is a government organization based out in New Delhi, India. It is known for research contribution in the topics: Population & Government. The organization has 2945 authors who have published 2999 publications receiving 44942 citations. The organization is also known as: Union Government & Central Government.
Topics: Population, Government, Health care, Public health, Dielectric
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation).
Abstract: Guduchi (Tinospora cordifolia [Willd.] Miers) is a flagship rejuvenating herb of Ayurveda with reported anti-diabetic potential. In the present study, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation). Guduchi Churna (GC) was subjected to 07 times Bhavana separately with its own extracted juice, decoction and potable water, and dosage forms namely Svarasa Bhavita Guduchi Churna (SBGC), Kwatha Bhavita Guduchi Churna (KBGC), and Jala Bhavita Guduchi Churna (JBGC) were prepared. The present study was aimed to evaluate the role of Bhavana on the potentiation of therapeutic properties of Guduchi. Sequential solvent extracts (5%, 10%, 15% and 25%) of GC, SBGC, KBGC and JBGC were prepared in different solvents [phosphate buffer, hexane, dichloromethane (DCM), chloroform] and screened for the α-amylase and α-glucosidase inhibitory activity. The results revealed that phosphate buffer and DCM extracts of SBGC exhibited strong α-amylase inhibitory potential (>80% inhibition at 25% concentration) followed by KBGC, JBGC and GC with reference to the standard acarbose. In α-glucosidase inhibitory activity, maximum inhibition was observed in DCM and chloroform extracts of SBGC (>85% inhibition at 25% concentration), followed by KBGC (>80% inhibition at 25% concentration), JBGC and GC. In vivo anti-hyperglycemic studies were carried out by oral glucose tolerance test in Swiss albino mice. Test drugs (JBGC, KBGC, SBGC) treated groups showed marginal decrease of blood glucose levels in normo glycemic mice. However, the blood glucose level in test drug JBGC, KBGC and SBGC treated groups was still within normal range in overnight fasted mice. In oral glucose tolerance test, among all dosage forms SBGC (51.08%) produced a pronounced anti-hyperglycemic effect followed by KBGC (42.57%) at a dose of 520mg/kg. The GC, JBGC, KBGC and SBGC samples were also standardized using berberine (a well established anti-diabetic compound) as a marker compound by HPTLC fingerprint analysis. Findings of the present study indicate that SBGC and KBGC can be used in the treatment of diabetes mellitus and gives supporting evidence to Ayurvedic claims that the Bhavana process has pharmaceutico-therapeutic significance in Ayurvedic drug development.
21 citations
••
TL;DR: To evaluate the ovicidal and larvicidal activities of hexane, chloroform and methanol extracts of Gymnema sylvestre, Scilla peruvina, Rubia cordifolia and Elytraria acaulis roots against the eggs and larvae of Aedes aegypti L. aeEgypti and Culex quinquefasciatus Say.
21 citations
••
TL;DR: Findings suggest that AB guard against cardiometabolic syndrome in HFD fed rats by decreasing oxidative stress, TNF-α and normalizing NO production.
21 citations
••
TL;DR: The Chhota Udepur lamprophyres (CUL) as discussed by the authors is one of the longest known lamp-rophyre dykes from the Narmada rift zone.
21 citations
••
TL;DR: A single cohort study conducted at Nutech Mediworld, New Delhi as discussed by the authors was aimed at establishing the safety of human embryonic stem cells (hESC) therapy in patients with terminal/incurable conditions.
Abstract: BACKGROUND Human embryonic stem cells (hESCs) are pluripotent cells that have the potential to self-renew and differentiate into all types of human cells. PURPOSE The present study was aimed at establishing the safety of hESC therapy in patients with terminal/incurable conditions. METHODS This was a single cohort study conducted at Nutech Mediworld, New Delhi. The patients suffering from various degenerative diseases were included in the study from year 2002 to 2004. hESCs (0.25 mL) were injected under skin in the abdominal wall. The safety of hESC therapy was evaluated by assessing the AEs experienced by patients during the study. Any disabling symptom/ sign, teratoma or antigen-antibody reaction that a patient suffered post transplantation of hESCs was considered as an AE. RESULTS A total of four, six and twenty three patients received hESC therapy in the year 2002, 2003 and 2004 respectively. Pain and fever were the most common AEs observed during the study. Other AEs included headache, mild pain in the abdomen, swelling of legs (edema), urinary tract infection (UTI), rash/erythema, pain at the lower back and limbs and body ache. All the AEs reported were mild in nature and resolved within one or two days with symptomatic medication and rest. No serious AEs were reported. The improvement in specific parameters of the patients was observed after the therapy. CONCLUSION hESCs used in the present study are safe for use in humans afflicted with incurable/terminal conditions. Future, prospective controlled studies to substantiate the present study are ongoing.
21 citations
Authors
Showing all 2961 results
Name | H-index | Papers | Citations |
---|---|---|---|
M. Santosh | 103 | 1344 | 49846 |
Rakesh Kumar | 91 | 1959 | 39017 |
Sankaran Subramanian | 74 | 332 | 24680 |
S. V. Subramanian | 72 | 444 | 17132 |
Amit Kumar | 65 | 1618 | 19277 |
Arvind Subramanian | 64 | 220 | 20452 |
Rakesh Sharma | 60 | 673 | 14157 |
Anil Mishra | 55 | 178 | 10505 |
Kaushik Basu | 54 | 323 | 13030 |
Pulok K. Mukherjee | 54 | 296 | 10873 |
Maharaj K. Bhan | 53 | 207 | 11841 |
Kuldeep Singh | 51 | 431 | 11815 |
Rakesh Tuli | 47 | 165 | 7497 |
Dipak Kumar Sahoo | 47 | 234 | 7293 |
M. Rajeevan | 46 | 164 | 9115 |